Serial high-resolution computed tomography imaging in patients with wegener granulomatosis: differentiation between active inflammatory and chronic fibrotic lesions

Purpose: To evaluate pulmonary pathologies in Wegener granulomatosis with sequential computed tomography (CT) in order to differentiate active inflammatory lesions from chronic fibrotic lesions. Material and Methods: Serial CT findings in 38 patients with Wegener granulomatosis were retrospectively analyzed (mean follow-up period, 21 months). The presence, extension, and distribution of the following findings were evaluated with CT: parenchymal nodules, masses, ground-glass attenuation, airspace consolidation, bronchial wall-thickening, bronchiectasis, linear areas of attenuation, pleural irregularities, pleural effusions, hilar and mediastinal lymphadenopathy. Results: Observed in 92% of patients, nodules were the most common CT pathology. Areas of ground-glass attenuation, consolidation, masses of linear attenuation, and tracheal/bronchial wall-thickening were detected in 24%, 26%, 32%, 39%, and 68% of patients. At follow-up, the clearance of lesions was most consistent for areas of ground-glass attenuation (89%), masses (87%), and cavitated nodules (85%). In the follow-up scan, 58% of all nodules, 47% of pulmonary consolidations, and 66% of bronchial wall-thickening were completely resolved. Areas of bronchiectasis and septal/non-septal lines remained stable in 70% and 71% of patients. Conclusion: The majority of the lesions decreased or resolved completely with or without areas of linear attenuation. Ground-glass attenuation, cavitated nodules and masses appear to represent active inflammatory lesions. In most probability, areas of bronchiectasis and septal/non-septal lines more often represent chronic fibrotic changes rather than active inflammatory changes. In combination with clinical evaluation and bronchoscopy, CT assists in the assessment of disease activity.

[1]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. , 2010, Arthritis and rheumatism.

[2]  Armin Schnabel,et al.  Active disease and residual damage in treated Wegener's granulomatosis: an observational study using pulmonary high-resolution computed tomography , 2002, European Radiology.

[3]  Guy Hoffman,et al.  Surgical Pathology of the Lung in Wegener's Granulomatosis: Review of 87 Open Lung Biopsies From 67 Patients , 1991, The American journal of surgical pathology.

[4]  E. Fishman,et al.  Wegener granulomatosis: CT features of parenchymal lung disease. , 1991, Journal of computer assisted tomography.

[5]  L. Donnelly,et al.  Pneumonia in children: decreased parenchymal contrast enhancement--CT sign of intense illness and impending cavitary necrosis. , 1997, Radiology.

[6]  H. Peter,et al.  Radiographic course of pulmonary manifestations in Wegener's granulomatosis under immunosuppressive therapy. , 1994, Chest.

[7]  D. Flieder,et al.  Treated Wegener's granulomatosis: distinctive pathological findings in the lungs of 20 patients and what they tell us about the natural history of the disease. , 1997, Human pathology.

[8]  R. Porter Nomenclature of Systemic Vasculitides: Proposal of an International Consensus Conference , 1995 .

[9]  R. Loire,et al.  Pulmonary Wegener's granulomatosis. A clinical and imaging study of 77 cases. , 1990, Chest.

[10]  D. Aberle,et al.  Asbestos-related pleural and parenchymal fibrosis: detection with high-resolution CT. , 1988, Radiology.

[11]  T. Paakkala,et al.  Contrast enhancement of round atelectases. , 2002, Acta radiologica.

[12]  M. Heller,et al.  Pulmonary Wegener's granulomatosis: correlation between high-resolution CT findings and clinical scoring of disease activity. , 1998, Chest.

[13]  M. Heller,et al.  Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. , 1994, Arthritis and rheumatism.

[14]  J. Lie Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis. , 2010, Arthritis and rheumatism.

[15]  N. Müller,et al.  Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. , 1987, Radiology.

[16]  F. Wegener The histopathological definition of Wegener's granulomatosis , 1990, APMIS. Supplementum.

[17]  C. Flower,et al.  Computed tomography of the lung in Wegener's granulomatosis. , 1993, Clinical radiology.

[18]  B. Haynes,et al.  Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. , 1983, Annals of internal medicine.

[19]  P. Attali,et al.  Pulmonary Wegener's granulomatosis: changes at follow-up CT , 1998, European Radiology.

[20]  D. Lynch,et al.  Thoracic manifestations of Wegener granulomatosis: diagnosis and course. , 1990, Radiology.

[21]  D. Lynch,et al.  Normal and diseased isolated lungs: high-resolution CT. , 1988, Radiology.

[22]  Takeshi Johkoh,et al.  Thoracic manifestation of Wegener's granulomatosis: CT findings in 30 patients , 2002, European Radiology.

[23]  M. Siegel,et al.  Wegener's granulomatosis in children: chest radiographic manifestations. , 1994, AJR. American journal of roentgenology.

[24]  N. Müller,et al.  Lung nodule enhancement at CT: multicenter study. , 2000, Radiology.

[25]  Y. Yoshikawa,et al.  Pulmonary lesions in Wegener's granulomatosis: a clinicopathologic study of 22 autopsy cases. , 1986, Human pathology.

[26]  G. Berry,et al.  Pneumocystis carinii Pneumonia: CT and HRCT Observations , 1990, Journal of computer assisted tomography.

[27]  A. D. Kornblut,et al.  Wegener's granulomatosis. , 1974, Otolaryngologic clinics of North America.